Integrating Cosme to vigilance into Pharmacy Practice: A Clinical Pharmacist’s Perspective

Abstract

According to the Drugs and Cosmetics Act of 1940, cosmetics in India comprise items for oral hygiene, skin,
hair, and nails. Despite rules, dermatitis and other Adverse Cosmetic Responses (ACRs) are nevertheless frequent.
Underreporting of ACRs is a result of both low customer awareness and a lack of pre-market testing. It is recommended
to solve this by putting in place a cosmetovigilance framework similar to the French ANSM system.Presentation of the
Case:
After utilizing a recently released herbal cosmetic lotion, a 35-year-old woman experienced severe face dermatitis. She
had no prior medical history of allergies or skin disorders. Patch testing and clinical analysis revealed hypersensitivity
to an unidentified product component. The patient recovered fully in two weeks after the lotion was stopped and topical
corticosteroids and antihistamines were administered.A healthcare provider submitted a structured adverse event report,
and the manufacturer was notified of the incidence.Discussion and Conclusion: This case draws attention to regulatory
shortcomings in India, specifically the lack of proper product labeling and required pre-market safety testing. A
coordinated framework for cosmetovigilance can help stakeholders monitor ACRs together and enhance post-market
surveillance. When it comes to reporting, informing consumers, and encouraging safer cosmetic procedures, clinical
pharmacists are essential. Cosmotovigilance can greatly improve the regulatory environment and lower the incidence of
adverse event reports (ACRs) in India by promoting adverse event reporting.